XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
July 2021 Equity Issuance
Public Offering
4SC Royalty Settlement
Common Stock
Common Stock
July 2021 Equity Issuance
Common Stock
Public Offering
Common Stock
4SC Royalty Settlement
Additional Paid-In Capital
Additional Paid-In Capital
July 2021 Equity Issuance
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
4SC Royalty Settlement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020         21,168,240                  
Beginning balance at Dec. 31, 2020 $ 158,785       $ 2       $ 266,823       $ (4,112) $ (103,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (34,534)                         (34,534)
Stock-based compensation 1,579               1,579          
Foreign exchange translation adjustment 2,991                       2,991  
Ending balance (in shares) at Mar. 31, 2021         21,749,439                  
Ending balance at Mar. 31, 2021 137,446       $ 2       277,027       (1,121) (138,462)
Beginning balance (in shares) at Dec. 31, 2020         21,168,240                  
Beginning balance at Dec. 31, 2020 158,785       $ 2       266,823       (4,112) (103,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (71,760)                          
Ending balance (in shares) at Sep. 30, 2021         26,249,439                  
Ending balance at Sep. 30, 2021 145,465       $ 3       321,950       (800) (175,688)
Beginning balance (in shares) at Mar. 31, 2021         21,749,439                  
Beginning balance at Mar. 31, 2021 137,446       $ 2       277,027       (1,121) (138,462)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (17,934)                         (17,934)
Stock-based compensation 1,507               1,507          
Foreign exchange translation adjustment (277)                       (277)  
Issuance of common stock (in shares)               581,199            
Issuance of common stock       $ 8,625               $ 8,625    
Ending balance (in shares) at Jun. 30, 2021         21,749,439                  
Ending balance at Jun. 30, 2021 120,742       $ 2       278,534       (1,398) (156,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (19,292)                         (19,292)
Stock-based compensation 1,397               1,397          
Foreign exchange translation adjustment 598                       598  
Issuance of common stock (in shares)           4,500,000                
Issuance of common stock   $ 42,020       $ 1       $ 42,019        
Ending balance (in shares) at Sep. 30, 2021         26,249,439                  
Ending balance at Sep. 30, 2021 $ 145,465       $ 3       321,950       (800) (175,688)
Beginning balance (in shares) at Dec. 31, 2021 26,335,418       26,335,418                  
Beginning balance at Dec. 31, 2021 $ 127,115       $ 3       324,237       (252) (196,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (20,808)                         (20,808)
Stock-based compensation 2,069               2,069          
Foreign exchange translation adjustment (58)                       (58)  
Issuance of common stock (in shares)         852   2,904,113              
Issuance of common stock 5   $ 29,638           5   $ 29,638      
Ending balance (in shares) at Mar. 31, 2022         29,240,383                  
Ending balance at Mar. 31, 2022 $ 137,961       $ 3       355,949       (310) (217,681)
Beginning balance (in shares) at Dec. 31, 2021 26,335,418       26,335,418                  
Beginning balance at Dec. 31, 2021 $ 127,115       $ 3       324,237       (252) (196,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss $ (63,933)                          
Ending balance (in shares) at Sep. 30, 2022 30,564,995       30,564,995                  
Ending balance at Sep. 30, 2022 $ 108,810       $ 3       369,999       (386) (260,806)
Beginning balance (in shares) at Mar. 31, 2022         29,240,383                  
Beginning balance at Mar. 31, 2022 137,961       $ 3       355,949       (310) (217,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (21,901)                         (21,901)
Stock-based compensation 2,062               2,062          
Foreign exchange translation adjustment (350)                       (350)  
Issuance of common stock (in shares)         24,612   1,300,000              
Issuance of common stock 130   $ 9,946           130   $ 9,946      
Ending balance (in shares) at Jun. 30, 2022         30,564,995                  
Ending balance at Jun. 30, 2022 127,848       $ 3       368,087       (660) (239,582)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (21,224)                         (21,224)
Stock-based compensation 1,912               1,912          
Foreign exchange translation adjustment $ 274                       274  
Ending balance (in shares) at Sep. 30, 2022 30,564,995       30,564,995                  
Ending balance at Sep. 30, 2022 $ 108,810       $ 3       $ 369,999       $ (386) $ (260,806)